Third Point Sets Sights On Nabi, Again

Nov 2 2006 | 11:54am ET

If there’s one thing we’ve learned about Daniel Loeb of Third Point, it’s that he makes good on his threats.

The activist hedge fund manager has filed a proxy statement seeking to boot five members–a majority–of the board of Nabi Biopharmaceuticals, including its CEO, Thomas McLain. Third Point owns 8.4% of the Boca Raton, Fla.-based company.
 
Last month, Nabi rejected Third Point’s demand to open its books to the New York-based hedge fund; the company said its management allowed inspection of only a “limited subset” of its documents. At the time, Third Point said it would proceed with a consent solicitation.

Nabi has responded to Third Point's most recent move by releasing a statement saying that it would review Third Point’s filing and “will communicate with stockholders in due course.”

This is not the first time that Loeb and McLain have butted heads, and if history is any indication, McLain should freshen up his résumé. In April, Loeb alleged that “the longstanding relationship between Mr. McLain and the Lehman [Brothers] investment bankers will prevent the company from receiving objective advice that will lead to the creation of maximum shareholder value.” Nabi responded by hiring Bank of America, a move praised by Loeb.


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

Often seen as a passion project, or part of a philanthropic venture, rare and fine stringed instruments offer an exciting option to diversify one’s investment portfolio while providing an opportunity for an exceptional long-term investment.